Macrophages emerged as key regulators, utilizing the CXCL12/CXCR4 axis to recruit CD8+ effector T cells and regulatory T cells (Tregs) into the tumor microenvironment (TME) (Zhang Y. et al., 2025). The gene discussed is CXCL12; the disease is neoplasm.